Sort
23,748 grants matching “melanoma”
Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas
$633,869Duane A. Mitchell · University Of Florida · R01 · FY2017 · CA
Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas
$633,869Duane A. Mitchell · University Of Florida · R01 · FY2018 · CA
Processed Antigen Characterization by Mass Spectrometry
$633,862Donald F Hunt · University Of Virginia · R01 · FY2015 · AI
Mechanisms of cAMP-dependent regulation of melanosome pH
$633,749Jonathan Hale Zippin · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · AR
Receptor Mediated SPECT Imaging Of Kaposi Sarcoma With 99mTc-Tilmanocept
$633,492Frederick Oliver Cope · Navidea Biopharmaceuticals, Inc. · R44 · FY2016 · CA
Bladder cancer PD-L1 control of homologous recombination: Basic mechanisms applied to novel treatments
$633,409Tyler J. Curiel · Dartmouth-Hitchcock Clinic · R01 · FY2025 · CA
Sustaining antitumor effector CD8+ T cells for cancer therapy
$633,355Bin Zhang · Northwestern University At Chicago · R01 · FY2024 · CA
Tumor-specific T cell state dynamics and heterogeneity in early tumorigenesis
$633,251Andrea Schietinger · Sloan-Kettering Inst Can Research · U54 · FY2020 · CA
Impact of mutation burden on cancer growth and the immune landscape
$633,201Shridar Ganesan · Rbhs -Cancer Institute Of New Jersey · R01 · FY2022 · CA
The Nodal Signaling Pathway In Embryonic Development
$633,104Michael Kuehn · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
A Multi-Level Investigation of US Indoor Tanning PolicyEnactment, Implementation, Compliance, Impact, and Economics
$632,923Carolyn J. Heckman · Rbhs -Cancer Institute Of New Jersey · R01 · FY2022 · CA
Project 3: Tools for Capturing Immune Cell/Cancer Cell Interactions in Cancer Immunotherapies and Combination Immunotherapies
$632,739James R. Heath · Institute For Systems Biology · U54 · FY2019 · CA
Gamma delta T cell based melanoma therapies
$632,718Xiaowei Xu · University Of Pennsylvania · R01 · FY2023 · CA
Targeting B7-H3 in ovarian cancer
$632,310Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Integrative Targeted Therapy for Melanoma
$632,195Jin-Ming Yang · University Of Kentucky · R01 · FY2024 · CA
Therapy with fecal microbiota transplantation and immune checkpoint blockade for solid tumors
$632,135Hassane M Zarour · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · CA
Innate NLRC4 signaling controls adaptive immune responses
$632,133Fayyaz S. Sutterwala · Cedars-Sinai Medical Center · R01 · FY2025 · AI
THE X FACTOR: WHAT ENDOWS WOMEN WITH A BETTER CHANCE OF SURVIVAL FROM MELANOMA?
$632,080University Of Sydney · · FY2025 · Defense Health Agency
Mechanisms of Durable Antitumor Immunity Mediated by PI3K-targeted T cells
$632,039Chrystal Mary Paulos · Emory University · R01 · FY2025 · CA
The Genetics of Ocular Melanoma
$632,004Anne Mary Bowcock · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA
UV-INDUCED EPIGENETIC FIELD EFFECT AS A TARGET FOR MELANOMA THERAPY AND PREVENTION
$632,000Temple University-Of The Commonwealth System Of Higher Education · · FY2016 · Department of Defense
MULTIMODAL GNAQ SIGNALING: PRECISION THERAPY FOR METASTATIC UVEAL MELANOMA PREVENTION AND TREATMENT
$632,000University Of California, San Diego · · FY2021 · Department of the Army
Sleep and Cancer: Evaluation of Risk and Insights into Mechanisms
$631,932Peggy Reynolds · Cancer Prevention Instit Of California · R01 · FY2017 · CA
Targeting dsRNA sensing and ADAR1 in melanoma
$631,778Jeffrey J. Ishizuka · Yale University · R37 · FY2024 · CA
Targeting dsRNA sensing and ADAR1 in melanoma
$631,778Jeffrey J. Ishizuka · Yale University · R37 · FY2025 · CA